Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 9
2019 6
2020 9
2021 16
2022 12
2023 14
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy of oligometastatic prostate cancer: a systematic review.
Rogowski P, Roach M 3rd, Schmidt-Hegemann NS, Trapp C, von Bestenbostel R, Shi R, Buchner A, Stief C, Belka C, Li M. Rogowski P, et al. Among authors: schmidt hegemann ns. Radiat Oncol. 2021 Mar 9;16(1):50. doi: 10.1186/s13014-021-01776-8. Radiat Oncol. 2021. PMID: 33750437 Free PMC article.
ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer.
Schmidt-Hegemann NS, Zamboglou C, Mason M, Mottet N, Hinnen K, De Meerleer G, Cozzarini C, Maingon P, Henry A, Spahn M, Cornford P, Belka C, Wiegel T. Schmidt-Hegemann NS, et al. Radiother Oncol. 2023 Jun;183:109544. doi: 10.1016/j.radonc.2023.109544. Epub 2023 Feb 20. Radiother Oncol. 2023. PMID: 36813168
Radiotherapy in nodal oligorecurrent prostate cancer.
Pinkawa M, Aebersold DM, Böhmer D, Flentje M, Ghadjar P, Schmidt-Hegemann NS, Höcht S, Hölscher T, Müller AC, Niehoff P, Sedlmayer F, Wolf F, Zamboglou C, Zips D, Wiegel T. Pinkawa M, et al. Among authors: schmidt hegemann ns. Strahlenther Onkol. 2021 Jul;197(7):575-580. doi: 10.1007/s00066-021-01778-1. Epub 2021 Apr 29. Strahlenther Onkol. 2021. PMID: 33914101 Free PMC article. Review.
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy.
Spohn SKB, Schmidt-Hegemann NS, Ruf J, Mix M, Benndorf M, Bamberg F, Makowski MR, Kirste S, Rühle A, Nouvel J, Sprave T, Vogel MME, Galitsnaya P, Gschwend JE, Gratzke C, Stief C, Löck S, Zwanenburg A, Trapp C, Bernhardt D, Nekolla SG, Li M, Belka C, Combs SE, Eiber M, Unterrainer L, Unterrainer M, Bartenstein P, Grosu AL, Zamboglou C, Peeken JC. Spohn SKB, et al. Among authors: schmidt hegemann ns. Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2537-2547. doi: 10.1007/s00259-023-06195-3. Epub 2023 Mar 16. Eur J Nucl Med Mol Imaging. 2023. PMID: 36929180 Free PMC article.
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml.
Solomonidou N, Germanou D, Strouthos I, Karagiannis E, Farolfi A, Koerber SA, Debus J, Peeken JC, Vogel ME, Vrachimis A, Spohn SKB, Shelan M, Aebersold D, Grosu AL, Ceci F, Kroeze SGC, Guckenberger M, Fanti S, Belka C, Hruby G, Scharl S, Wiegel T, Bartenstein P, Henkenberens C, Emmett L, Schmidt-Hegemann NS, Ferentinos K, Zamboglou C. Solomonidou N, et al. Among authors: schmidt hegemann ns. Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2529-2536. doi: 10.1007/s00259-023-06185-5. Epub 2023 Mar 11. Eur J Nucl Med Mol Imaging. 2023. PMID: 36905411 Free PMC article.
Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate Cancer.
Zamboglou C, Peeken JC, Janbain A, Katsahian S, Strouthos I, Ferentinos K, Farolfi A, Koerber SA, Debus J, Vogel ME, Combs SE, Vrachimis A, Morganti AG, Spohn SKB, Shelan M, Aebersold DM, Grosu AL, Ceci F, Henkenberens C, Kroeze SGC, Guckenberger M, Fanti S, Belka C, Bartenstein P, Hruby G, Scharl S, Wiegel T, Emmett L, Arnoux A, Schmidt-Hegemann NS. Zamboglou C, et al. Among authors: schmidt hegemann ns. JAMA Netw Open. 2023 May 1;6(5):e2314748. doi: 10.1001/jamanetworkopen.2023.14748. JAMA Netw Open. 2023. PMID: 37219907 Free PMC article.
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.
Adebahr S, Althaus A, Scharl S, Strouthos I, Farolfi A, Serani F, Lanzafame H, Trapp C, Koerber SA, Peeken JC, Vogel MME, Vrachimis A, Spohn SKB, Grosu AL, Kroeze SGC, Guckenberger M, Fanti S, Hruby G, Emmett L, Belka C, Schmidt-Hegemann NS, Henkenberens C, Aebersold DM, Wiegel T, Afshar-Oromieh A, Zamboglou C, Shelan M. Adebahr S, et al. Among authors: schmidt hegemann ns. Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):558-567. doi: 10.1007/s00259-023-06438-3. Epub 2023 Sep 22. Eur J Nucl Med Mol Imaging. 2024. PMID: 37736808 Free PMC article.
[Retroperitoneal soft tissue sarcoma: role of radiotherapy].
Nieto A, Albertsmeier M, Werner J, Di Gioia D, Lindner LH, Rauch J, Nachbichler S, Belka C, Schmidt-Hegemann NS. Nieto A, et al. Among authors: schmidt hegemann ns. Chirurg. 2022 Jan;93(1):34-39. doi: 10.1007/s00104-021-01498-3. Epub 2021 Sep 15. Chirurg. 2022. PMID: 34524488 Review. German.
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus.
Spohn SKB, Draulans C, Kishan AU, Spratt D, Ross A, Maurer T, Tilki D, Berlin A, Blanchard P, Collins S, Bronsert P, Chen R, Pra AD, de Meerleer G, Eade T, Haustermans K, Hölscher T, Höcht S, Ghadjar P, Davicioni E, Heck M, Kerkmeijer LGW, Kirste S, Tselis N, Tran PT, Pinkawa M, Pommier P, Deltas C, Schmidt-Hegemann NS, Wiegel T, Zilli T, Tree AC, Qiu X, Murthy V, Epstein JI, Graztke C, Gao X, Grosu AL, Kamran SC, Zamboglou C. Spohn SKB, et al. Among authors: schmidt hegemann ns. Int J Radiat Oncol Biol Phys. 2023 Jul 1;116(3):503-520. doi: 10.1016/j.ijrobp.2022.12.038. Epub 2022 Dec 31. Int J Radiat Oncol Biol Phys. 2023. PMID: 36596346 Free article. Review.
Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer.
Mehrens D, Kramer KKM, Unterrainer LM, Beyer L, Bartenstein P, Froelich MF, Tollens F, Ricke J, Rübenthaler J, Schmidt-Hegemann NS, Herlemann A, Unterrainer M, Kunz WG. Mehrens D, et al. Among authors: schmidt hegemann ns. J Natl Compr Canc Netw. 2023 Jan;21(1):43-50.e2. doi: 10.6004/jnccn.2022.7070. J Natl Compr Canc Netw. 2023. PMID: 36634610
62 results